Skip to main content
logo
FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
1.355
-0.005 (-0.37%)
Sep 25, 2026, 12:49 PM EDT - Market open

FibroBiologics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
91570---
Market Cap Growth
-57.21%-78.68%----
Enterprise Value
71764---
Last Close Price
1.364.5040.00---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
1.782.4325.66---
P/TBV Ratio
2.042.4325.66---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.320.393.861.39-1.88-1.18
Net Debt / Equity Ratio
-0.44-0.40-1.25-5.92-1.32-0.87
Net Debt / EBITDA Ratio
0.130.150.250.84--
Net Debt / FCF Ratio
0.140.150.281.08-1.29-0.79
Quick Ratio
1.592.781.101.000.320.23
Current Ratio
2.643.611.121.000.370.27
Return on Equity (ROE)
-660.08%-419.44%-559.73%---
Return on Assets (ROA)
-95.77%-79.85%-60.75%-66.75%-105.51%-
Return on Capital Employed (ROCE)
-292.70%-211.80%-369.40%-337.00%198.60%122.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-191.72%-124.64%-15.90%---
FCF Yield
-156.39%-111.34%-17.22%---
Buyback Yield / Dilution
-112.97%-35.85%-16.45%--222.64%-
SEC Filings: 10-K · 10-Q